drugset

drugset / Trial / NCT05280782

Development and Translation of Generator-Produced PET Tracer for Myocardial Perfusion Imaging-Dosimetry Group

NCT05280782 ↗

Phase 0 Completed 8 enrolled Washington University School of Medicine National Heart, Lung, and Blood Institute (NHLBI) · collab National Institutes of Health (NIH) · collab

NaSingle-groupOpen-labelDiagnostic

Summary

This study is a single center, early phase 1 clinical imaging study designed to assess the dosimetry of 68Ga-Galmydar for PET/CT imaging.

Timeline

Start: 2022-01-05
Primary completion: 2022-05-01
Completion: 2022-05-01

Publications

Background Sivapackiam J, Laforest R, Sharma V. 68Ga[Ga]-Galmydar: Biodistribution and radiation dosimetry studies in rodents. Nucl Med Biol. 2018 Apr;59:29-35. doi: 10.1016/j.nucmedbio.2017.11.008. Epub 2017 Dec 1.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Galmydar	Diagnostic / imaging agent	296 mbq	Intravenous

Indications